Piramal Enterprises Limited (PEL.NS)
INR 1115.7
(-2.78%)
INR 1115.7
(-2.78%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 63.65 Billion INR | 763.63% |
| 2022 | 3.33 Billion INR | -92.41% |
| 2021 | 43.97 Billion INR | 101.14% |
| 2020 | 21.86 Billion INR | -57.64% |
| 2019 | 51.6 Billion INR | 9.47% |
| 2018 | 47.13 Billion INR | 12.53% |
| 2017 | 41.88 Billion INR | 11.19% |
| 2016 | 37.67 Billion INR | 6.96% |
| 2015 | 35.22 Billion INR | 15.85% |
| 2014 | 30.4 Billion INR | 8.16% |
| 2013 | 28.1 Billion INR | 32.79% |
| 2012 | 21.16 Billion INR | 74.19% |
| 2011 | 12.15 Billion INR | 18.6% |
| 2010 | 10.24 Billion INR | -35.32% |
| 2009 | 15.84 Billion INR | 155.88% |
| 2008 | 6.19 Billion INR | -52.56% |
| 2007 | 13.05 Billion INR | 21.88% |
| 2006 | 10.7 Billion INR | 30.03% |
| 2005 | 8.23 Billion INR | 54.43% |
| 2004 | 5.33 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 2.89 Billion INR | 7.55% |
| 2024 Q1 | 2.69 Billion INR | -63.22% |
| 2023 Q1 | -15.52 Billion INR | -2245.82% |
| 2023 FY | 28.83 Billion INR | 763.63% |
| 2023 Q3 | 5.76 Billion INR | 20.04% |
| 2023 Q2 | 4.8 Billion INR | 130.96% |
| 2023 Q4 | 7.32 Billion INR | 27.09% |
| 2022 Q3 | 5.58 Billion INR | 3.24% |
| 2022 FY | 3.33 Billion INR | -92.41% |
| 2022 Q1 | 14.73 Billion INR | 57.63% |
| 2022 Q2 | 5.41 Billion INR | -63.27% |
| 2022 Q4 | 723.3 Million INR | -87.05% |
| 2021 FY | 43.97 Billion INR | 101.14% |
| 2021 Q3 | 12.37 Billion INR | 8.54% |
| 2021 Q1 | 10.35 Billion INR | 261.64% |
| 2021 Q4 | 9.34 Billion INR | -24.47% |
| 2021 Q2 | 11.4 Billion INR | 10.08% |
| 2020 Q4 | -6.4 Billion INR | -168.94% |
| 2020 FY | 21.86 Billion INR | -57.64% |
| 2020 Q1 | 9.73 Billion INR | -36.61% |
| 2020 Q2 | 9.98 Billion INR | 2.57% |
| 2020 Q3 | 9.29 Billion INR | -6.93% |
| 2019 Q3 | 13.06 Billion INR | 21.29% |
| 2019 FY | 51.6 Billion INR | 9.47% |
| 2019 Q2 | 10.76 Billion INR | -12.43% |
| 2019 Q4 | 15.35 Billion INR | 17.59% |
| 2019 Q1 | 12.29 Billion INR | 27.52% |
| 2018 FY | 47.13 Billion INR | 12.53% |
| 2018 Q2 | 12.77 Billion INR | 8.89% |
| 2018 Q1 | 11.73 Billion INR | -3.13% |
| 2018 Q4 | 9.64 Billion INR | -22.55% |
| 2018 Q3 | 12.45 Billion INR | -2.53% |
| 2017 FY | 41.88 Billion INR | 11.19% |
| 2017 Q4 | 12.11 Billion INR | 1.87% |
| 2017 Q3 | 11.88 Billion INR | 16.96% |
| 2017 Q2 | 10.16 Billion INR | 0.27% |
| 2017 Q1 | 10.13 Billion INR | -7.21% |
| 2016 FY | 37.67 Billion INR | 6.96% |
| 2016 Q4 | 10.92 Billion INR | 11.76% |
| 2016 Q3 | 9.77 Billion INR | 2.79% |
| 2016 Q2 | 9.5 Billion INR | 6.69% |
| 2016 Q1 | 8.91 Billion INR | -7.21% |
| 2015 Q4 | 9.6 Billion INR | 2.33% |
| 2015 Q1 | 9.14 Billion INR | 32.94% |
| 2015 Q2 | 8.64 Billion INR | -5.53% |
| 2015 Q3 | 9.38 Billion INR | 8.65% |
| 2015 FY | 35.22 Billion INR | 15.85% |
| 2014 Q1 | 7.72 Billion INR | 3.59% |
| 2014 Q4 | 6.87 Billion INR | -11.87% |
| 2014 Q2 | 7.55 Billion INR | -2.2% |
| 2014 FY | 30.4 Billion INR | 8.16% |
| 2014 Q3 | 7.8 Billion INR | 3.33% |
| 2013 Q1 | 6.34 Billion INR | 13.09% |
| 2013 FY | 28.1 Billion INR | 32.79% |
| 2013 Q4 | 7.45 Billion INR | 3.13% |
| 2013 Q3 | 7.23 Billion INR | 2.12% |
| 2013 Q2 | 7.08 Billion INR | 11.62% |
| 2012 Q4 | 5.6 Billion INR | 0.77% |
| 2012 Q2 | 5.77 Billion INR | 36.14% |
| 2012 Q1 | 4.24 Billion INR | 6.88% |
| 2012 Q3 | 5.56 Billion INR | -3.58% |
| 2012 FY | 21.16 Billion INR | 74.19% |
| 2011 Q3 | 3.55 Billion INR | 0.0% |
| 2011 FY | 12.15 Billion INR | 18.6% |
| 2011 Q4 | 3.96 Billion INR | 11.48% |
| 2010 FY | 10.24 Billion INR | -35.32% |
| 2009 FY | 15.84 Billion INR | 155.88% |
| 2008 FY | 6.19 Billion INR | -52.56% |
| 2007 FY | 13.05 Billion INR | 21.88% |
| 2006 FY | 10.7 Billion INR | 30.03% |
| 2005 FY | 8.23 Billion INR | 54.43% |
| 2004 FY | 5.33 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Sigachi Industries Limited | 579.88 Million INR | -10876.759% |
| Ind-Swift Limited | 946.56 Million INR | -6624.595% |
| Bajaj HealthCare Limited | 985.34 Million INR | -6359.951% |
| Sakar Healthcare Limited | 204.07 Million INR | -31090.274% |
| Aurobindo Pharma Limited | 55.65 Billion INR | -14.364% |
| Innova Captab Limited | 931.03 Million INR | -6736.815% |
| Divi's Laboratories Limited | 14.17 Billion INR | -349.208% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -2473.39% |
| Morepen Laboratories Limited | 1.98 Billion INR | -3102.737% |
| Mankind Pharma Limited | 29.27 Billion INR | -117.446% |
| Sequent Scientific Limited | 2.9 Billion INR | -2093.555% |
| Wanbury Limited | 978.96 Million INR | -6402.044% |
| Laurus Labs Limited | 11.9 Billion INR | -434.457% |
| Nectar Lifesciences Limited | 932.7 Million INR | -6724.574% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -446.813% |
| Alembic Limited | 872.45 Million INR | -7195.801% |
| Hikal Limited | 4.46 Billion INR | -1325.978% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | -301.096% |
| Neuland Laboratories Limited | 2.92 Billion INR | -2072.639% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | -330.303% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | -35.568% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -2791.995% |
| Themis Medicare Limited | 1.12 Billion INR | -5554.016% |
| RPG Life Sciences Limited | 1.63 Billion INR | -3791.947% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 49.164% |
| Lupin Limited | 125.09 Billion INR | 49.117% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -2939.717% |
| Wockhardt Limited | 8.48 Billion INR | -650.623% |
| Vaishali Pharma Limited | 84.02 Million INR | -75650.991% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -1970.414% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -14414.377% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -340.382% |
| FDC Limited | 3.49 Billion INR | -1718.777% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 33.611% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -15333.713% |
| Eris Lifesciences Limited | 4.94 Billion INR | -1187.752% |
| Venus Remedies Limited | 1.91 Billion INR | -3221.679% |
| ZIM Laboratories Limited | 1.01 Billion INR | -6183.234% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -4385.049% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -109103.917% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -2827.238% |
| Shilpa Medicare Limited | 3.33 Billion INR | -1809.101% |
| Albert David Limited | 1.02 Billion INR | -6103.088% |
| Ajanta Pharma Limited | 30.46 Billion INR | -108.953% |
| Hester Biosciences Limited | 908.84 Million INR | -6903.741% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -4437.589% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -2392.181% |
| Gufic Biosciences Limited | 1.18 Billion INR | -5264.351% |
| Windlas Biotech Limited | 1 Billion INR | -6224.11% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -2025.018% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -447749.152% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -39136.63% |
| Granules India Limited | 10.31 Billion INR | -517.221% |
| Aarti Drugs Limited | 1.16 Billion INR | -5352.158% |
| Bal Pharma Limited | 555.62 Million INR | -11356.051% |
| Alkem Laboratories Limited | 32.83 Billion INR | -93.857% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 58.716% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -5825.678% |
| Medicamen Biotech Limited | 335.16 Million INR | -18891.368% |
| Unichem Laboratories Limited | 6.72 Billion INR | -846.388% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -13871.663% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -933225.513% |
| Valiant Laboratories Limited | 138.02 Million INR | -46015.526% |
| Orchid Pharma Limited | 800.77 Million INR | -7848.939% |
| Medico Remedies Limited | 59.67 Million INR | -106565.773% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -2896.577% |
| Ipca Laboratories Limited | 18.98 Billion INR | -235.234% |
| Brooks Laboratories Limited | 51.18 Million INR | -124270.457% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -18316.297% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | -197.136% |
| NATCO Pharma Limited | 10.05 Billion INR | -532.857% |
| Suven Life Sciences Limited | 109.75 Million INR | -57897.995% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -137807.964% |
| Strides Pharma Science Limited | 9.16 Billion INR | -594.725% |
| Indoco Remedies Limited | 12.06 Billion INR | -427.748% |
| Alpa Laboratories Limited | 127.38 Million INR | -49870.796% |
| Lasa Supergenerics Limited | 291.17 Million INR | -21760.743% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -1968.799% |